Introduction {#sec1_1}
============

Even though liposarcomas account for 10--20% of all mesenchymal malignancies, they are extremely rarely located in the stomach. We report the case of a female patient with large gastric liposarcoma that was finally managed by proximal gastrectomy. The patient has been alive without any sign of recurrence since 2012.

Case Report {#sec1_2}
===========

In November 2011, a 48-year-old woman, who had been periodically checked for submucosal tumour below the esophagogastric junction since 2004, was presented with melena and anaemia (haemoglobin level 7.5 g/dL) (Fig. [1](#F1){ref-type="fig"}). CT revealed a giant hypoechogenic tumour subcardially on the posterior gastric wall, size 70 × 50 × 55 mm (Fig. [2](#F2){ref-type="fig"}). Endoscopic tumour resection by piecemeal technique was done under general anaesthesia in December 2011, and a lipoma was confirmed on histopathological examination. A recurrent bleeding tumour was proven 6 weeks later by endoscopy. The patient was indicated for surgery. A laparoscopic resection of the tumour on the anterior wall of the stomach just below the cardia was performed using linear staplers. A well-differentiated liposarcoma, lipoma-like variant, was discovered. The resection margin was assessed as R1. The patient underwent an open proximal gastrectomy with pyloroplasty 2 months later with no signs of residual tumour in the resected specimen.

During the postoperative period, balloon and bougie dilations were repeatedly performed as well as an endoscopic pyloromyotomy in November 2015, due to persistent problems with gastric emptying. The patient received supplementary enteral nutrition until November 2016 because of unsufficient peroral intake with ongoing body weight loss. Five years later, our patient had been without recurrence or any somatic difficulties. Compared to her pre-operative status, the significant body weight loss was still present (58 vs. 47 kg; BMI 20.1 vs. 16.3). Her laboratory results did not show any malnutrition, however. Moreover, they were better than pre-operatively (total protein 67.3 vs. 73.2 g/L; albumin 38.2 vs. 52.3 g/L). The level of haemoglobin was 13.3 g/dL.

Discussion {#sec1_3}
==========

Liposarcomas, although the most common mesenchymal malignancy of all, are rarely seen in the gastrointestinal tract. Since first described in 1941 by Abrams et al., only 37 cases of gastric liposarcoma have been published in English in the literature to date \[[@B1]\]. Most liposarcomas were located in the antrum or lesser curvature, esophagogastric junction involvement as in our case was reported only once \[[@B2]\].

The peak incidence for gastric liposarcomas is in the 6th and 7th decade of life. The etiology remains unclear; however, some patients have a positive family history for any soft tissue tumour that suggests genetic factors may play a role in the origin of gastric liposarcomas \[[@B3]\]. Gastric liposarcomas originate from undifferentiated mesenchymal cells in the submucosal and muscular layers of the stomach wall, and an exophytic growth is typical \[[@B1], [@B4]\]. The characteristic histological feature of the tumour is a presence of immature fat cells and lipoblasts \[[@B4]\]. Histologically, they are classified and divided into 5 subtypes (well-differentiated/dedifferentiated, myxoid, round cells, and pleomorphic) \[[@B1], [@B3], [@B5]\].

There are no characteristic clinical findings, and patients may remain asymptomatic for a long period − which was also the case of our patient who had been periodically checked by endoscopy for 7 years due to likely gastric lipoma. Symptoms depend predominantly on the location and size of the tumour and the presence of ulceration \[[@B6]\]. Mechanical obstruction, gastrointestinal bleeding and palpable mass belong to the most common symptoms. Generally, nonspecific symptoms are the main reason for a delayed diagnosis.

The final diagnosis is mostly based on a histopathological examination of the resected specimen. Endoscopic biopsies may fail because the submucosa remains intact as long as the tumour is not ulcerating. The most effective examination is a CT scan. The presence of a well-circumscribed fatty dense tumour within the submucosa with enhanced areas supports the diagnosis \[[@B7]\]. CT can also exclude any potential secondary lesions and lymphadenopathy. A relation between CT findings and histopathological type was reported: well-differentiated liposarcomas show a classic heterogeneous density, liquid cystic changes are typical for myxoid type and round cells, and pleomorphic types are characterized by a non-specific solid structure \[[@B7], [@B8]\]. Differential diagnosis includes lipoma, stromal tumour (gastrointestinal stromal tumour), lymphoma, peritoneal liposarcoma, or hepatic metastasis adjacent to the stomach \[[@B9], [@B10], [@B11]\].

The treatment method of choice is surgical removal. The type of resection depends on the location and size of the tumour and varies from a small excision to total gastrectomy. A wide resection margin to ensure R0 is highly recommended, as well. Lymphadenectomy seems not to be necessary because of a lack of lymph node involvement. Currently, there is no evidence of efficacy of chemotherapy or radiotherapy even though few reported patients have been treated with these methods \[[@B1]\]. Due to a high risk of local recurrence, adjuvant therapy might be beneficial.

Conclusion {#sec1_4}
==========

The CT findings of a submucosal fatty tumour with heterogeneous density within the gastric wall should raise the suspicion for liposarcoma. The goal is a surgical removal of the tumour with sufficient margins ensuring R0 resection.
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